Cargando…

Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors

The approval of the first HIV-1 protease inhibitors (HIV-1 PRIs) marked a fundamental step in the control of AIDS, and this class of agents still represents the mainstay therapy for this illness. Despite the undisputed benefits, the necessary lifelong treatment led to numerous severe side-effects (m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monica, Gabriele La, Lauria, Antonino, Bono, Alessia, Martorana, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200130/ https://www.ncbi.nlm.nih.gov/pubmed/34199858 http://dx.doi.org/10.3390/ijms22116070

Ejemplares similares

Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
por: La Monica, Gabriele, et al.
Publicado: (2022)

In Silico Design of New Dual Inhibitors of SARS-CoV-2 M(PRO) through Ligand- and Structure-Based Methods
por: Bono, Alessia, et al.
Publicado: (2023)

In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents
por: Bono, Alessia, et al.
Publicado: (2023)

Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways
por: Martorana, Annamaria, et al.
Publicado: (2020)

Design and Synthesis of Novel Thieno[3,2-c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells
por: La Monica, Gabriele, et al.
Publicado: (2023)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
por: Martorana, Annamaria, et al.
Publicado: (2020)

Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel
por: Martorana, Annamaria, et al.
Publicado: (2022)

In Silico Identification of Small Molecules as New Cdc25 Inhibitors through the Correlation between Chemosensitivity and Protein Expression Pattern
por: Lauria, Antonino, et al.
Publicado: (2021)

Antiproliferative Properties and G-Quadruplex-Binding of Symmetrical Naphtho[1,2-b:8,7-b’]dithiophene Derivatives
por: Lauria, Antonino, et al.
Publicado: (2021)

Synthesis, biological evaluation, and in silico studies of novel chalcone- and pyrazoline-based 1,3,5-triazines as potential anticancer agents
por: Moreno, Leydi M., et al.
Publicado: (2020)

HIV protease inhibitors: a review of molecular selectivity and toxicity
por: Lv, Zhengtong, et al.
Publicado: (2015)

Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products
por: Chávez-Hernández, Ana L., et al.
Publicado: (2021)

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta
por: Longo, Valeria, et al.
Publicado: (2020)

Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers
por: Goda, Jayant S., et al.
Publicado: (2016)

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites
por: Naito, Yuki, et al.
Publicado: (2015)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L
por: Phan, Hoang Anh T., et al.
Publicado: (2021)

Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases
por: Jiang, Longguang, et al.
Publicado: (2018)

Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009)

General and Modular Strategy for Designing Potent, Selective, and Pharmacologically Compliant Inhibitors of Rhomboid Proteases
por: Tichá, Anežka, et al.
Publicado: (2017)

Targeting flexibility: a structure-based computational study revealing allosteric HIV-1 protease inhibitors
por: Kunze, Jens, et al.
Publicado: (2014)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors
por: Kumar, Prateek, et al.
Publicado: (2019)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
por: Yu, Wei, et al.
Publicado: (2021)

Design, synthesis, and in vitro evaluation of aza-peptide aldehydes and ketones as novel and selective protease inhibitors
por: Corrigan, Thomas S., et al.
Publicado: (2020)

Data-Driven Exploration of Selectivity and Off-Target Activities of Designated Chemical Probes
por: Miljković, Filip, et al.
Publicado: (2018)

Novel inhibitors and activity-based probes targeting serine proteases
por: Ferguson, Timothy E. G., et al.
Publicado: (2022)

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites
por: Alfonso, Yenisey, et al.
Publicado: (2011)

Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani, Imène, et al.
Publicado: (2013)

Applications of Click Chemistry in the Development of HIV Protease Inhibitors
por: Mudgal, Mukesh M., et al.
Publicado: (2018)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

Efficient Strategy to Design Protease Inhibitors: Application to Enterovirus 71 2A Protease
por: Chen, Ting, et al.
Publicado: (2022)

The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors
por: Silvestrini, Lucia, et al.
Publicado: (2021)

Molecular Dynamics Study on Selected Bioactive Phytochemicals as Potential Inhibitors of HIV-1 Subtype C Protease
por: Shode, Francis Oluwole, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vlikgmancp78ji3lmkiasdge01